Abstract
Inhibition of the renin-angiotensin system (RAS) has been shown to have beneficial effects in cardiovascular disease prognosis and therapy.Discovery of (pro)renin receptor [(P)RR] revealed that (P)RR upon binding to both renin or prorenin in their proenzyme inactive form made them enzymatically active, thus aiding the catalytic conversion of angiotensinogen (AGT) to angiotensin (Ang) I. This binding also transduces intracellular signal to the nucleus via various pathways. Our recent research elucidated the physiological roles of (P)RR in cell life, wherein it acts as an essential accessory protein of vacuolar H+-ATPase (V-ATPase) as well as an adaptor protein of Wnt signaling. The present review provides insights into a novel approach to cardiovascular diseases, which will open the gates to new therapeutic approaches for treating cardiovascular diseases.
Keywords: (Pro)renin receptor, vascuolar H+-ATPase, direct renin inhibitor.
Current Pharmaceutical Design
Title:Novel Approach to Cardiovascular Diseases: A Promising Probability of (Pro)Renin Receptor [(P)RR]
Volume: 20 Issue: 14
Author(s): Takashi Ando and Atsuhiro Ichihara
Affiliation:
Keywords: (Pro)renin receptor, vascuolar H+-ATPase, direct renin inhibitor.
Abstract: Inhibition of the renin-angiotensin system (RAS) has been shown to have beneficial effects in cardiovascular disease prognosis and therapy.Discovery of (pro)renin receptor [(P)RR] revealed that (P)RR upon binding to both renin or prorenin in their proenzyme inactive form made them enzymatically active, thus aiding the catalytic conversion of angiotensinogen (AGT) to angiotensin (Ang) I. This binding also transduces intracellular signal to the nucleus via various pathways. Our recent research elucidated the physiological roles of (P)RR in cell life, wherein it acts as an essential accessory protein of vacuolar H+-ATPase (V-ATPase) as well as an adaptor protein of Wnt signaling. The present review provides insights into a novel approach to cardiovascular diseases, which will open the gates to new therapeutic approaches for treating cardiovascular diseases.
Export Options
About this article
Cite this article as:
Ando Takashi and Ichihara Atsuhiro, Novel Approach to Cardiovascular Diseases: A Promising Probability of (Pro)Renin Receptor [(P)RR], Current Pharmaceutical Design 2014; 20 (14) . https://dx.doi.org/10.2174/13816128113199990472
DOI https://dx.doi.org/10.2174/13816128113199990472 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Diabetes and Antioxidants: Myth or Reality?
Current Vascular Pharmacology Role of Curcumin in Modulating Plasma PON1 Arylesterase Activity and Susceptibility to LDL Oxidation in Oxidatively Challenged Wistar Rats
Letters in Drug Design & Discovery Immune Response Towards Snake Venoms
Inflammation & Allergy - Drug Targets (Discontinued) Cardiovascular Complications of Obesity
Current Respiratory Medicine Reviews Prostaglandin EP Receptor Subtypes Involved in Regulating HCO3- Secretion from Gastroduodenal Mucosa
Current Pharmaceutical Design Effect of Inhibition of Intestinal Cholesterol Absorption on the Prevention of Cholesterol Gallstone Formation
Medicinal Chemistry Medicinal Plants for the Prevention and Treatment of Bacterial Infections
Current Pharmaceutical Design The Promise of Plant Polyphenols as the Golden Standard Skin Anti-Inflammatory Agents
Current Drug Metabolism New Therapeutic Aspects of Inflammatory Cardiomyopathy
Current Pharmaceutical Design Oral Inflammation and Bacteremia: Implications for Chronic and Acute Systemic Diseases Involving Major Organs
Cardiovascular & Hematological Disorders-Drug Targets Investigating Drug-induced Mitochondrial Toxicity: A Biosensor to Increase Drug Safety?
Current Drug Safety Energy Expenditure of Hunter-Gatherers: When Statistics Turns to be Unreliable
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial: Pharmacological Therapy to Prevent Sudden Cardiac Death: Indications and Limitations in the Era of Devices
Mini-Reviews in Medicinal Chemistry Chromatographic Fingerprinting and Metabolomics for Quality Control of TCM
Combinatorial Chemistry & High Throughput Screening A Scientific Approach to Anti-Ageing Therapies: State of the Art
Current Pharmaceutical Design Cardiac Adiposity and Cardiovascular Risk: Potential Role of Epicardial Adipose Tissue
Current Cardiology Reviews Inflammation Markers in Essential Hypertension
Medicinal Chemistry The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue
CNS & Neurological Disorders - Drug Targets Lower Financial Status and Adherence to Medication Determines 10-Year (2004-2014) All-Cause Mortality and Risk for Acute Coronary Syndrome Incidence Among Cardiac Patients: the GREECS Study
Current Vascular Pharmacology Substance-Related Disorders and Somatic Symptoms: How Should Clinicians Understand the Associations?
Current Drug Abuse Reviews